MBX Biosciences Inc. Comm... (MBX)
MBX Biosciences Common Stock Max Pain By Strike
MBX trades at $16.32, 18.4% below the near-term max pain of $20 expiring Oct 17, 2025 (11 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is rising across expirations ($2.5-$22.5), reflecting growing call interest at higher strikes. Key magnetic zone at 18 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
MBX Biosciences Common Stock Max Pain By Expiry
Max pain for MBX shows an upward trend from 2.5 to 22.5, suggesting bullish positioning in longer-dated options. The 160% spread signals divergent expectations across timeframes. Levels distributed around 16.32. Strong magnetic level at 18 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Oct 17, 2025 | 20 | n/a (n/a) |
| Nov 21, 2025 | 15 | n/a (n/a) |
| Dec 19, 2025 | 17.5 | n/a (n/a) |
| Jan 16, 2026 | 12.5 | n/a (n/a) |
| Feb 20, 2026 | 17.5 | n/a (n/a) |
| Mar 20, 2026 | 2.5 | n/a (n/a) |
| Apr 17, 2026 | 10 | n/a (n/a) |
| May 15, 2026 | 2.5 | n/a (n/a) |
| Jul 17, 2026 | 17.5 | n/a (n/a) |
| Dec 18, 2026 | 5 | n/a (n/a) |
| Jan 15, 2027 | 7.5 | n/a (n/a) |
| Jan 21, 2028 | 22.5 | n/a (n/a) |